drugset / Trial / NCT05515419
Allogeneic Cord Blood for Neurological Diseases in Adults
NaSingle-groupOpen-labelTreatment
Summary
This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood therapy for adult patients with neurological diseases.
Timeline
- Start
- 2025-07-01
- Primary completion
- 2026-09-30
- Completion
- 2026-11-30
Outcome
Outcome not reported
Stopped: “Due to regulatory reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic cord blood treatment | Unknown | — | — |